Pharmaceutical formulation impacts the bioavailability of a given drug and is therefore one of the key factors in the successful development of a new medicine. However, many of the drugs in the development pipelines often possess poor physico-chemical properties, which make them difficult to formulate using classic approaches and hence require the use of new and enabling formulation approaches.
Join Dr. Rob Harris, Chief Technical Officer at Juniper Pharma Services, who will present “A bitter pill to swallow – Developing medicines for Paediatrics”.
A great opportunity to meet your R&D peers, and gain more knowledge about this important topic at this meeting featuring about 125 delegates and 12 exhibitors. The event will be covered by the press.
Date: March 21th, 2018
Time: 09.00 – 16.00
Place: Medicon Valley Alliance, Copenhagen
Address: Edvard Thomsens Vej 14, Ørestaden